![]() |
市場調查報告書
商品編碼
1666940
穀胱甘肽市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測Glutathione Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球穀胱甘肽市場價值為 2.529 億美元,預計 2025 年至 2034 年期間的複合年成長率為 6.8%。穀胱甘肽廣泛用於藥物、化妝品和膳食補充劑,由於其具有中和自由基和支持整體健康的能力,其需求正在上升。
在製藥領域,穀胱甘肽在解決與解毒、氧化壓力和老化相關的健康問題方面發揮關鍵作用。其在醫療保健領域的不斷擴展的應用極大地促進了其市場的成長。化妝品產業也利用穀胱甘肽對皮膚健康的有益作用,推動對美容和護膚產品的需求。此外,將其作為免疫增強劑添加到膳食補充劑中引起了注重健康的消費者的興趣,進一步刺激了市場需求。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 2.529 億美元 |
預測值 | 4.887 億美元 |
複合年成長率 | 6.8% |
還原穀胱甘肽 (GSH) 部分在 2024 年佔據市場主導地位,營收達 1.621 億美元。這種形式的穀胱甘肽以其優越的生物利用度和有效性而聞名,使其成為各種應用中的首選。作為一種強大的抗氧化劑,GSH 在解毒、免疫系統支持和對抗氧化壓力方面發揮著至關重要的作用。它在醫療保健、美容和保健領域的突出地位凸顯了其日益成長的重要性,而生產技術的進步不斷提高其可及性。
醫藥應用仍是穀胱甘肽市場的主要驅動力,2024 年市場規模達 1.142 億美元。正在進行的研究和創新為其利用開闢了新的途徑,鞏固了其作為醫療重要成分的地位。
美國穀胱甘肽市場價值在 2024 年將達到 7,120 萬美元,預計到 2034 年將以 7.1% 的複合年成長率成長。穀胱甘肽在健康和個人護理領域的應用日益廣泛,再加上研究和生物技術的進步,進一步增強了美國市場的前景
The Global Glutathione Market was valued at USD 252.9 million in 2024 and is projected to grow at a CAGR of 6.8% between 2025 and 2034. This growth is primarily fueled by the increasing awareness of glutathione's antioxidant properties and its health-enhancing benefits. Widely used in pharmaceuticals, cosmetics, and dietary supplements, glutathione's demand is on the rise due to its ability to neutralize free radicals and support overall well-being.
In the pharmaceutical sector, glutathione plays a critical role in addressing health issues related to detoxification, oxidative stress, and aging. Its expanding application in healthcare has significantly contributed to its market growth. The cosmetic industry also leverages glutathione for its beneficial effects on skin health, driving demand for beauty and skincare products. Additionally, its inclusion in dietary supplements as an immunity booster has captured the interest of health-conscious consumers, further bolstering market demand.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $252.9 Million |
Forecast Value | $488.7 Million |
CAGR | 6.8% |
The reduced glutathione (GSH) segment dominated the market in 2024, accounting for USD 162.1 million in revenue. This form of glutathione is known for its superior bioavailability and effectiveness, making it a preferred choice across various applications. As a powerful antioxidant, GSH plays an essential role in detoxification, immune system support, and combating oxidative stress. Its prominence in the healthcare, beauty, and wellness sectors underscores its growing importance, while advancements in production techniques continue to enhance its accessibility.
Pharmaceutical applications remain a key driver of the glutathione market, generating USD 114.2 million in 2024. The use of glutathione in therapeutic formulations, particularly for addressing oxidative damage and detoxification, highlights its critical role in healthcare. Ongoing research and innovation are opening new avenues for its utilization, reinforcing its status as a vital ingredient in medical treatments.
The U.S. glutathione market, valued at USD 71.2 million in 2024, is expected to grow at a CAGR of 7.1% through 2034. The robust healthcare infrastructure and increasing consumer interest in health-promoting products are fueling growth in this region. The rising use of glutathione in wellness and personal care, combined with advancements in research and biotechnology, further strengthens the market's outlook in the U.S.